TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 26 filers reported holding TITAN PHARMACEUTICALS INC DE in Q1 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107 | -50.0% | 230 | -30.3% | 0.00% | – |
| Q2 2023 | $214 | -21.6% | 330 | 0.0% | 0.00% | – |
| Q1 2023 | $273 | +15.2% | 330 | +8.9% | 0.00% | – |
| Q4 2022 | $237 | -99.3% | 303 | -99.5% | 0.00% | – |
| Q2 2022 | $33,000 | -41.1% | 59,504 | +1.0% | 0.00% | – |
| Q1 2022 | $56,000 | +21.7% | 58,904 | +31.6% | 0.00% | – |
| Q4 2021 | $46,000 | +64.3% | 44,757 | +198.5% | 0.00% | – |
| Q3 2021 | $28,000 | -63.6% | 14,996 | -49.2% | 0.00% | – |
| Q2 2021 | $77,000 | -64.7% | 29,518 | -59.6% | 0.00% | – |
| Q1 2021 | $218,000 | +7166.7% | 73,113 | +8971.1% | 0.00% | – |
| Q4 2020 | $3,000 | – | 806 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 39,820 | $119,000 | 0.02% |
| Westside Investment Management, Inc. | 8 | $0 | 0.00% |
| American Portfolios Advisors | 23 | $69 | 0.00% |
| JPMORGAN CHASE & CO | 78 | $0 | 0.00% |
| ROYAL BANK OF CANADA | 17 | $0 | 0.00% |
| VANGUARD GROUP INC | 72,791 | $217,000 | 0.00% |
| UBS Group AG | 23,459 | $70,000 | 0.00% |
| Sowell Financial Services LLC | 19 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 15 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 138 | $0 | 0.00% |